Ovid Therapeutics Inc
(OVID)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,611 | 28,415 | 21,136 | 26,301 | 15,017 |
| Marketable Securities | 4,992 | 9,932 | 21,860 | 26,774 | 47,695 |
| Other current assets | 3,221 | 3,742 | 2,925 | 2,865 | 3,115 |
| TOTAL | $28,824 | $42,089 | $45,921 | $55,940 | $65,827 |
| Non-Current Assets | |||||
| PPE Net | 269 | 285 | 346 | 433 | 509 |
| Investments And Advances | 20,908 | 20,908 | 20,908 | 20,974 | 21,125 |
| Other Non-Current Assets | 13,847 | 14,146 | 14,479 | 14,820 | 15,193 |
| TOTAL | $35,024 | $35,339 | $35,733 | $36,227 | $36,827 |
| Total Assets | $63,848 | $77,428 | $81,654 | $92,167 | $102,654 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,710 | 3,950 | 1,950 | 3,192 | 2,710 |
| Accrued Expenses | 2,959 | 2,872 | 5,997 | 5,994 | 7,607 |
| TOTAL | $6,796 | $8,924 | $9,307 | $10,522 | $11,630 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 718 | 718 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 972 |
| TOTAL | $12,354 | $12,715 | $13,070 | $13,419 | $14,734 |
| Total Liabilities | $19,150 | $21,639 | $22,377 | $23,941 | $26,364 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,212 | 71,110 | 71,110 | 71,075 | 71,010 |
| Common Shares | 71 | 71 | 71 | 71 | 71 |
| Retained earnings | -331,376 | -319,218 | -314,533 | -304,299 | -295,045 |
| Other shareholders' equity | -126 | -69 | -48 | -35 | 36 |
| TOTAL | $44,698 | $55,789 | $59,276 | $68,226 | $76,290 |
| Total Liabilities And Equity | $63,848 | $77,428 | $81,653 | $92,167 | $102,654 |